Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device could make colon polyp removal safer and faster

NCT ID NCT07263997

Symptom relief Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study tests a new traction device called SureTrac to help doctors remove large colorectal lesions (precancerous growths) more easily. The device pulls the lesion upward during a procedure called submucosal dissection, which may make the surgery faster, safer, and more likely to remove the entire lesion in one piece. The trial will include 30 adults with colorectal lesions larger than 2 cm who are eligible for this type of removal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Nov 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient, male or female, aged ≥ 18 years old * Patient with a colorectal lesion larger than 2 cm * Patient eligible for SMD with elastic traction * Patient affiliated with or beneficiary of a social security scheme * French-speaking patient who has signed an informed consent form Exclusion Criteria: * Patients in poor general health who should not undergo endoscopy. * Patients with an upper digestive tract that cannot be accessed by the endoscope. * Patients with severe coagulation disorders and diseases associated with a risk of haemorrhage (platelets \<50G/L, PT \< 50%, INR \> 1.5, APTT \>1.5). * Patients who are allergic to the instrument and to the drugs administered during the operation * Patients who are not compatible with the use of the product according to the diagnosis Patients with lesions located in the appendix, ileocecal valve or within a diverticulum * Patients with lesions that present a risk of deep submucosal invasion based on their morphological appearance (Kudo lesion \> 10 mm or Sano IIIB \> 10 mm or connect III) * Patients with recurrence of a lesion previously resected by endoscopy or surgery * Patients with a history of chronic inflammatory bowel disease (IBD) or familial adenomatous polyposis (FAP) * Patients with a history of pelvic radiotherapy * Patients for whom follow-up data cannot be collected * Pregnant women * Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision * Patients hospitalised without consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal cancer (msi-H) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal cancer (msi-H)

Contacts and locations

Locations

  • Hôpital Privé Jean Mermoz

    Lyon, 69008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.